Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2022-01-28
DOI
10.1080/14712598.2022.2026921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort
- (2021) Anna Kernder et al. LUPUS
- Autoimmune Complications in Hematologic Neoplasms
- (2021) Wilma Barcellini et al. Cancers
- CAR T cells: Building on the CD19 paradigm
- (2021) Anat Globerson Levin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Global epidemiology of systemic lupus erythematosus
- (2021) Megan R. W. Barber et al. Nature Reviews Rheumatology
- CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
- (2021) Dimitrios Mougiakakos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy
- (2021) Lei Xue et al. Cell Discovery
- Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis
- (2021) Jun Meng et al. Frontiers in Oncology
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
- (2020) Scott A. Jenks et al. IMMUNITY
- ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
- (2020) S. Depil et al. NATURE REVIEWS DRUG DISCOVERY
- B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making
- (2020) Katerina Gemenetzi et al. Frontiers in Oncology
- Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus
- (2020) Xuexiao Jin et al. Cellular & Molecular Immunology
- Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
- (2020) Sonia Guedan et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of anifrolumab in systemic lupus erythematosus: a critical analysis of the TULIP trials
- (2020) Nanda Gamad et al. LUPUS
- CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD
- (2020) Yuki Imura et al. JCI Insight
- Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
- (2020) Jinmin Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Autoimmune Diseases in the Prognosis of Lymphoma
- (2020) Pierluigi Masciopinto et al. Journal of Clinical Medicine
- Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
- (2019) Rita Kansal et al. Science Translational Medicine
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- New therapies for systemic lupus erythematosus — past imperfect, future tense
- (2019) Grainne Murphy et al. Nature Reviews Rheumatology
- Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
- (2019) Kevin O. Saunders Frontiers in Immunology
- Chimeric antigen receptor T‐cell therapy’s role in antiphospholipid syndrome: a case report
- (2019) Jacob L. Schmelz et al. BRITISH JOURNAL OF HAEMATOLOGY
- B cell targeted therapies in autoimmune disease
- (2019) Jennifer L Barnas et al. CURRENT OPINION IN IMMUNOLOGY
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus
- (2018) Jessica Neely et al. CURRENT OPINION IN RHEUMATOLOGY
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of Antibody Drug Delivery
- (2018) Sahar Awwad et al. Pharmaceutics
- Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
- (2018) Liliana Michelle Gomez Mendez et al. Clinical Journal of the American Society of Nephrology
- Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes
- (2018) Li Zhang et al. JOURNAL OF AUTOIMMUNITY
- Systemic lupus erythematosus: Diagnosis and clinical management
- (2018) Andrea Fava et al. JOURNAL OF AUTOIMMUNITY
- Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
- (2018) Judith Feucht et al. NATURE MEDICINE
- Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases
- (2017) Fredrik N. Albach et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular and molecular pathways of structural damage in rheumatoid arthritis
- (2017) Ulrike Harre et al. Seminars in Immunopathology
- Pemphigus
- (2017) Michael Kasperkiewicz et al. Nature Reviews Disease Primers
- Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
- (2016) V. G. Bhoj et al. BLOOD
- T cells in Systemic Lupus Erythematosus
- (2016) Abel Suárez-Fueyo et al. CURRENT OPINION IN IMMUNOLOGY
- Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
- (2016) Katherine G. MacDonald et al. JOURNAL OF CLINICAL INVESTIGATION
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- Systemic lupus erythematosus
- (2016) Arvind Kaul et al. Nature Reviews Disease Primers
- CAR therapy: the CD19 paradigm
- (2015) Michel Sadelain JOURNAL OF CLINICAL INVESTIGATION
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Human autoimmune diseases: a comprehensive update
- (2015) Lifeng Wang et al. JOURNAL OF INTERNAL MEDICINE
- Synthetic biology in cell-based cancer immunotherapy
- (2015) Deboki Chakravarti et al. TRENDS IN BIOTECHNOLOGY
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- Development of SLE among “potential SLE” patients seen in consultation: long-term follow-up
- (2014) M. Al Daabil et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
- (2014) Edmund A. Rossi et al. PLoS One
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA
- (2013) Ittai Fattal et al. IMMUNOLOGY
- B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
- (2013) Venkat Reddy et al. ARTHRITIS RESEARCH & THERAPY
- Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
- (2012) Scott M. Hayter et al. AUTOIMMUNITY REVIEWS
- Pathology of Multiple Sclerosis
- (2012) Markus Kipp et al. CNS & Neurological Disorders-Drug Targets
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- An Acquired Defect in IgG-Dependent Phagocytosis Explains the Impairment in Antibody-Mediated Cellular Depletion in Lupus
- (2011) A. Ahuja et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
- (2011) Tom L. Van Belle et al. PHYSIOLOGICAL REVIEWS
- Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus
- (2010) Kai W. Bekar et al. ARTHRITIS AND RHEUMATISM
- Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells
- (2010) J. N. Kochenderfer et al. BLOOD
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor
- (2009) Eran Elinav et al. GASTROENTEROLOGY
- A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
- (2009) Y. Zhao et al. JOURNAL OF IMMUNOLOGY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies
- (2009) Isaac T. W. Harley et al. NATURE REVIEWS GENETICS
- Molecular mechanisms of autoimmunity
- (2008) M. Zouhair Atassi et al. AUTOIMMUNITY
- Sites and Stages of Autoreactive B Cell Activation and Regulation
- (2008) Mark J. Shlomchik IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started